A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia.
Ishida H, Kawahara Y, Tomizawa D, Okamoto Y, Hama A, Cho Y, Koh K, Koga Y, Yoshida N, Sato M, Terui K, Miyagawa N, Watanabe A, Takita J, Kobayashi R, Yamamoto M, Watanabe K, Okada K, Kato K, Matsumoto K, Hino M, Tabuchi K, Sakaguchi H.
Ishida H, et al. Among authors: cho y.
J Hematol Oncol. 2024 Apr 29;17(1):24. doi: 10.1186/s13045-024-01548-3.
J Hematol Oncol. 2024.
PMID: 38679709
Free PMC article.